Hostname: page-component-8448b6f56d-c47g7 Total loading time: 0 Render date: 2024-04-20T01:40:14.521Z Has data issue: false hasContentIssue false
  • English
  • Français

Injections in health care settings: a risk factor for acute hepatitis B virus infection in Karachi, Pakistan

Published online by Cambridge University Press:  29 April 2003

H. R. USMAN ,
S. AKHTAR ,
M. H. RAHBAR ,
S. HAMID ,
T. MOATTAR  and
S. P. LUBY
H. R. USMAN
Affiliation:
Division of Epidemiology and Biostatistics, Department of Community Health Sciences, The Aga Khan University, PO Box 3500, Stadium Road, Karachi 74800, Pakistan
S. AKHTAR
Affiliation:
Division of Epidemiology and Biostatistics, Department of Community Health Sciences, The Aga Khan University, PO Box 3500, Stadium Road, Karachi 74800, Pakistan
M. H. RAHBAR
Affiliation:
Division of Epidemiology and Biostatistics, Department of Community Health Sciences, The Aga Khan University, PO Box 3500, Stadium Road, Karachi 74800, Pakistan
S. HAMID
Affiliation:
Department of Medicine, The Aga Khan University, PO Box 3500, Stadium Road, Karachi 74800, Pakistan
T. MOATTAR
Affiliation:
Department of Pathology, The Aga Khan University, PO Box 3500, Stadium Road, Karachi 74800, Pakistan
S. P. LUBY
Affiliation:
Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A case control study was conducted to identify the association of therapeutic injections with acute hepatitis B virus (HBV) infection in Karachi, Pakistan. We enrolled 67 cases of acute HBV infection (IgM anti-HBc positive) and 247 controls (anti-HBc negative) from four hospitals of Karachi during July 2000–June 2001. Exposure to various risk factors during the period relevant to the incubation period of HBV was recorded both from cases and controls using a structured questionnaire. Multivariate logistic regression analysis of the data showed that cases were more likely to have received one injection (OR=4·0; 95% CI 1·4, 11·1), or more than one injection (OR=6·3; 95% CI 3·2, 12·4) compared to controls. The estimated population attributable risk (PAR) for therapeutic injections was 53%. Also the cases compared to controls were more likely to have household size of seven or more (OR=1·9; 95% CI 0·95, 3·9). This study showed that unsafe therapeutic injections appear to be the major risk factor for acute HBV infection and needs immediate focus from public health stand point.

Type
Research Article
Information
Epidemiology & Infection , Volume 130 , Issue 2 , April 2003 , pp. 293 - 300
Copyright
© 2003 Cambridge University Press